Oscar Puig
Company: Nucleai
Job title: Vice President - Translational Medicine & Diagnostics
Seminars:
Panel Discussion: AI and Digital Pathology – Enabling Next-Gen Treatments & Diagnostics 2:15 pm
What impact does artificial intelligence (AI) and digital pathology (DP) have on biomarker strategy and drug development? How novel treatment modalities are driving innovative assays and AI-powered scoring frameworks How AI-powered biomarkers can be deployed for trial enrollment and patient selectionRead more
day: Day Three Track A